【推廣分享活動】 OHDSI Taiwan x 醫藥品查驗中心：推動健康資料治理與法規科學
OHDSI Taiwan x 醫藥品查驗中心：推動健康資料治理與法規科學
2025年4月28日，OHDSI Taiwan Society 的徐之昇理事長受邀前往財團法人醫藥品查驗中心（Center for Drug Evaluation, CDE），以「全球數位健康：創造多元真實世界數據與證據的價值」為題，進行專題分享與座談交流。
CDE 為衛生福利部食品藥物管理署（Taiwan Food and Drug Administration, TFDA）與中央健康保險署（National Health Insurance Administration, NHIA）之重要合作單位，長期推動我國健康技術評估（Health Technology Assessment, HTA）與相關法規科學的發展。此次分享聚焦於 OHDSI 在國際健康資料治理架構、法規科學支持機制與全球合作模式上的實踐經驗，並探討其在政策層面的應用潛力。
OHDSI 不僅是一個科研平台，更是一種促進政府、學界與產業對話的共同語言。我們期盼透過持續的交流，協助台灣強化健康資料政策的創新發展，並提升在全球法規科學與數位健康政策領域中的參與度與能見度。
#OHDSTITaiwan #RWD #RWE #資料治理 #法規科學 #HTA #TFDA #CDE #GlobalHealthData #OpenScience #健康資料政策接軌
OHDSI Taiwan x CDE: Advancing Health Data Governance and Regulatory Science
On April 28, 2025, Professor Jason C. Hsu, President of OHDSI Taiwan Society, was invited to the Center for Drug Evaluation (CDE) to deliver a keynote presentation titled “Global Digital Health: Creating Value Through Diverse Real-World Data and Evidence”, followed by a focused discussion session.
The CDE is a key partner of both the Taiwan Food and Drug Administration (TFDA) and the National Health Insurance Administration (NHIA), playing a pivotal role in driving Taiwan’s efforts in Health Technology Assessment (HTA) and regulatory science. In this session, Professor Hsu shared OHDSI’s international experience in health data governance, regulatory science support frameworks, and global collaboration models, highlighting their relevance and potential for policy applications.
OHDSI is more than just a scientific research platform—it is a common language that fosters dialogue among government, academia, and industry. Through continued engagement with public agencies, we aim to support innovative health data policy development and enhance Taiwan’s visibility and participation in global regulatory science and digital health initiatives.
#OHDSTITaiwan #RWD #RWE #DataGovernance #RegulatoryScience #HTA #TFDA #CDE #GlobalHealthData #OpenScience #HealthPolicyInnovation
